Medexprim, a member of BC Platforms group, is involved in major EU-funded projects, and is applying for further grant applications for public-private consortia.
#ARTEMIs
ARTEMIs aims to co-design and develop a POC of a Clinical Decision Support System— a cutting-edge clinical visualization
tool— offering an overview of patient multimodal data and therapeutic decision-aid, thanks to the integrated virtual twin models. The CDSS provides dynamic and multilevel representations of tissues and organs and will provide support to clinicians to achieve early diagnosis, prediction of disease evolution, assessment of cardiovascular outcomes, and guidance towards specific treatments or interventions. This will mark a significant leap forward in MAFLD patient’s healthcare.
ORGANS
PARTNERS
EU-FUNDING
Countries
PATIENTS
#EUCAIM
EUCAIM, the first-of-its-kind European pan-cancer infrastructure, is the cornerstone of the European Commission-initiated European Cancer Imaging Initiative, a flagship of Europe’s Beating Cancer Plan (EBCP). It aims to foster innovation and deployment of digital technologies to achieve more precise and faster clinical decision making, diagnostics, treatment and predictive medicine for cancer patients.
CANCERS
PARTNERS
EU-FUNDING
Countries
Project
#CHAIMELEON
CHAIMELEON aims to set up a structured repository for health imaging data to be openly reused in AI experimentation for cancer management, with the creation of four datalakes for four cancers: lung, breast, colorectal, prostate.
Medexprim is in charge of combining scientific sensitivity, maturity on technical platforms, a legal and regulatory knowledge and a collaborative spirit.
CANCERS
PARTNERS
EU-FUNDING
Countries
Project
#PRIMAGE
This project has succeeded in proposing an open cloud-based platform to support decision making in the clinical management of two paediatric cancers, Neuroblastoma (NB), the most frequent solid cancer of early childhood, and the Diffuse Intrinsic Pontine Glioma (DIPG), the leading cause of brain tumour-related death in children.
PEDIATRIC CANCERS
PARTNERS
Project